These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25684450)

  • 1. A [(32)P]NAD(+)-based method to identify and quantitate long residence time enoyl-acyl carrier protein reductase inhibitors.
    Yu W; Neckles C; Chang A; Bommineni GR; Spagnuolo L; Zhang Z; Liu N; Lai C; Truglio J; Tonge PJ
    Anal Biochem; 2015 Apr; 474():40-9. PubMed ID: 25684450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA.
    Bergler H; Fuchsbichler S; Högenauer G; Turnowsky F
    Eur J Biochem; 1996 Dec; 242(3):689-94. PubMed ID: 9022698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay.
    Afanador GA; Muench SP; McPhillie M; Fomovska A; Schön A; Zhou Y; Cheng G; Stec J; Freundlich JS; Shieh HM; Anderson JW; Jacobus DP; Fidock DA; Kozikowski AP; Fishwick CW; Rice DW; Freire E; McLeod R; Prigge ST
    Biochemistry; 2013 Dec; 52(51):9155-66. PubMed ID: 24295325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enoyl-ACP reductase (FabI) of Haemophilus influenzae: steady-state kinetic mechanism and inhibition by triclosan and hexachlorophene.
    Marcinkeviciene J; Jiang W; Kopcho LM; Locke G; Luo Y; Copeland RA
    Arch Biochem Biophys; 2001 Jun; 390(1):101-8. PubMed ID: 11368521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan.
    Ward WH; Holdgate GA; Rowsell S; McLean EG; Pauptit RA; Clayton E; Nichols WW; Colls JG; Minshull CA; Jude DA; Mistry A; Timms D; Camble R; Hales NJ; Britton CJ; Taylor IW
    Biochemistry; 1999 Sep; 38(38):12514-25. PubMed ID: 10493822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli enoyl-acyl carrier protein reductase (FabI) supports efficient operation of a functional reversal of β-oxidation cycle.
    Vick JE; Clomburg JM; Blankschien MD; Chou A; Kim S; Gonzalez R
    Appl Environ Microbiol; 2015 Feb; 81(4):1406-16. PubMed ID: 25527535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationalizing the Binding Kinetics for the Inhibition of the Burkholderia pseudomallei FabI1 Enoyl-ACP Reductase.
    Neckles C; Eltschkner S; Cummings JE; Hirschbeck M; Daryaee F; Bommineni GR; Zhang Z; Spagnuolo L; Yu W; Davoodi S; Slayden RA; Kisker C; Tonge PJ
    Biochemistry; 2017 Apr; 56(13):1865-1878. PubMed ID: 28225601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism and inhibition of the FabV enoyl-ACP reductase from Burkholderia mallei.
    Lu H; Tonge PJ
    Biochemistry; 2010 Feb; 49(6):1281-9. PubMed ID: 20055482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the Francisella tularensis enoyl-acyl carrier protein reductase (FabI) in complex with NAD(+) and triclosan.
    Mehboob S; Truong K; Santarsiero BD; Johnson ME
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Nov; 66(Pt 11):1436-40. PubMed ID: 21045289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures and kinetic properties of enoyl-acyl carrier protein reductase I from Candidatus Liberibacter asiaticus.
    Jiang L; Gao Z; Li Y; Wang S; Dong Y
    Protein Sci; 2014 Apr; 23(4):366-77. PubMed ID: 24407918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a potent enoyl-acyl carrier protein reductase (FabI) inhibitor suitable for antistaphylococcal agent.
    Kim YG; Seo JH; Kwak JH; Shin KJ
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4481-6. PubMed ID: 26343826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of Pyridone- and Diphenyl Ether-Based Inhibitors for the Yersinia pestis FabV Enoyl-ACP Reductase.
    Neckles C; Pschibul A; Lai CT; Hirschbeck M; Kuper J; Davoodi S; Zou J; Liu N; Pan P; Shah S; Daryaee F; Bommineni GR; Lai C; Simmerling C; Kisker C; Tonge PJ
    Biochemistry; 2016 May; 55(21):2992-3006. PubMed ID: 27136302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis.
    Heath RJ; Su N; Murphy CK; Rock CO
    J Biol Chem; 2000 Dec; 275(51):40128-33. PubMed ID: 11007778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein EnvM is the NADH-dependent enoyl-ACP reductase (FabI) of Escherichia coli.
    Bergler H; Wallner P; Ebeling A; Leitinger B; Fuchsbichler S; Aschauer H; Kollenz G; Högenauer G; Turnowsky F
    J Biol Chem; 1994 Feb; 269(8):5493-6. PubMed ID: 8119879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK).
    Marrakchi H; Dewolf WE; Quinn C; West J; Polizzi BJ; So CY; Holmes DJ; Reed SL; Heath RJ; Payne DJ; Rock CO; Wallis NG
    Biochem J; 2003 Mar; 370(Pt 3):1055-62. PubMed ID: 12487627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase.
    Massengo-Tiassé RP; Cronan JE
    J Biol Chem; 2008 Jan; 283(3):1308-1316. PubMed ID: 18032386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enoyl acyl carrier protein reductase inhibitors: an updated patent review (2011 - 2015).
    Zitko J; Doležal M
    Expert Opin Ther Pat; 2016 Sep; 26(9):1079-94. PubMed ID: 27399249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and enzymatic analyses reveal the binding mode of a novel series of Francisella tularensis enoyl reductase (FabI) inhibitors.
    Mehboob S; Hevener KE; Truong K; Boci T; Santarsiero BD; Johnson ME
    J Med Chem; 2012 Jun; 55(12):5933-41. PubMed ID: 22642319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyl-branched fatty acids, inhibitors of enoyl-ACP reductase with antibacterial activity from Streptomyces sp. A251.
    Zheng CJ; Sohn MJ; Chi SW; Kim WG
    J Microbiol Biotechnol; 2010 May; 20(5):875-80. PubMed ID: 20519910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.